CompletedNCT03896659
Exploring the Effects of Corticosteroids on the Human Hippocampus
Medication studyAges 18–50United StatesDepression
Understand this study
Who was this study for?
Listed age limits: 18 years to 50 years.
- Listed locations
- Dallas, United StatesSee all locations and recruitment
- Activities
- Medication described in the protocol · Placebo described in the protocol; its role is not resolved here
- Compensation
- Payment and expense reimbursement have not been verified.
Study information
Study start dateStarted: October 1, 2019
- Recruitment status
- Completed
- Enrollment listed in the registry
- 66
- Sponsor
- University of Texas Southwestern Medical Center
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 50 Years
- Official registry ID
- NCT03896659
- Official title
Show the full official title
Exploring the Effects of Corticosteroids on the Human Hippocampus Using Neurocognitive Testing and High Resolution Neuroimaging
Recruitment & locations
CompletedDallas
Questions about this study
Who is behind this study?
The study sponsor is University of Texas Southwestern Medical Center, a university.
Did this study involve medication?
Yes. The study involved medication, including Hydrocortisone Oral and Placebo Oral Tablet.
Who was this study for?
Listed age limits: 18 years to 50 years.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me